Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica.
about
Repurposing drugs for the treatment and control of helminth infectionsZoonotic helminth infections with particular emphasis on fasciolosis and other trematodiases.Structure-activity relationship of an ozonide carboxylic acid (OZ78) against Fasciola hepatica.In vivo and in vitro sensitivity of Fasciola hepatica to triclabendazole combined with artesunate, artemether, or OZ78The activity of dispiro peroxides against Fasciola hepatica.Disruption of spermatogenesis in the liver fluke, Fasciola hepatica by two artemisinin derivatives, artemether and artesunate.Pharmacokinetics of the Antischistosomal Lead Ozonide OZ418 in Uninfected Mice Determined by Liquid Chromatography-Tandem Mass SpectrometryTriclabendazole progress report, 2005-2009: an advancement of learning?In vitro and in vivo trematode models for chemotherapeutic studies.Current status of food-borne trematode infections.Development and validation of a liquid chromatography and ion spray tandem mass spectrometry method for the quantification of artesunate, artemether and their major metabolites dihydroartemisinin and dihydroartemisinin-glucuronide in sheep plasma.Ultrastructural changes to the tegumental system and gastrodermal cells of adult Fasciola hepatica following treatment in vivo with a commercial preparation of myrrh (Mirazid).Electron microscopical study to assess the in vitro effects of the synthetic trioxolane OZ78 against the liver fluke, Fasciola hepatica.Adult triclabendazole-resistant Fasciola hepatica: morphological changes in the tegument and gut following in vivo treatment with artemether in the rat model.Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica.Peroxides with Anthelmintic, Antiprotozoal, Fungicidal and Antiviral Bioactivity: Properties, Synthesis and Reactions.
P2860
Q26823355-308485CA-72CD-4F78-A5BC-9CABAAE3BBB9Q31080479-2393624D-9DAA-4EDE-AA6E-197ABF2F1A4CQ33899023-03A17104-029C-4F8C-BA66-61F67A32896EQ34290075-74D6B497-14FB-4C3B-B718-2F15EC148DFDQ35175961-94E2AEA3-C178-49EA-8980-23BC95FD8FE9Q35958217-4530020A-C8A2-47BF-B007-29B665692EC2Q37428688-9FA1E831-7BCC-4C67-A5D8-7F4C23D72622Q37444251-710A7606-E2B6-4835-81FE-1733EDB6246DQ37644571-ADE2D1F2-B358-4EF4-B277-2CBFADC20951Q37974131-26D3F911-2AF1-449D-94EC-1261DE2CC3BAQ38980419-D3E39E86-1A82-4B33-8B71-26C7FBF3D045Q40497193-02526F11-D993-48B9-B4E6-DBA24DF2AA0AQ42458074-2C5551B5-A003-4024-B6C1-2E15E0140312Q46050142-FA549DFE-1EB3-44C5-AD84-245399B34A51Q46200030-BDEF84AE-1AA9-44CA-B54A-44658E29F77DQ47664127-FA395732-F113-48D5-A9EA-7B7D05BF661B
P2860
Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica.
@en
Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica.
@nl
type
label
Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica.
@en
Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica.
@nl
prefLabel
Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica.
@en
Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica.
@nl
P2093
P1476
Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica.
@en
P2093
Gerry Brennan
Ian Fairweather
Jonathan L Vennerstrom
Yuxiang Dong
P304
P356
10.1016/J.TRSTMH.2007.07.012
P577
2007-10-01T00:00:00Z